Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Sebocytes play a key role in controlling androgen levels in human skin.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Too much androgen can cause hair loss; finasteride may help.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

A new gene, JMJD1C, may affect testosterone levels in men.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Cuscuta reflexa extract may help treat hair loss caused by hormones.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.